Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.

Lynn I Levin,Christina M Ramirez, Eileen L Liao, Hongyu Guo, Bong K Kim, Aizen J Marrogi,Larry I Magpantay,Elizabeth C Breen,Otoniel Martínez-Maza

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology（2023）

引用 0|浏览16

暂无评分

摘要

The increasing trajectories of the B-cell activation molecules, sCD30, CXCL13, and to a lesser extent IL10, may indicate early disease-induced effects or reflect the chronic stimulation of B-cells that promotes the development of FL and DLBCL subtypes.

查看译文

关键词

immune activation serum biomarkers,b-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要